1. Home
  2. KBH vs RCUS Comparison

KBH vs RCUS Comparison

Compare KBH & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KB Home

KBH

KB Home

HOLD

Current Price

$47.18

Market Cap

3.4B

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$25.18

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KBH
RCUS
Founded
1957
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.2B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
KBH
RCUS
Price
$47.18
$25.18
Analyst Decision
Hold
Buy
Analyst Count
14
10
Target Price
★ $56.17
$31.90
AVG Volume (30 Days)
1.3M
★ 1.5M
Earning Date
03-24-2026
05-05-2026
Dividend Yield
★ 1.91%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.96
N/A
Revenue
★ $4,547,002,000.00
$247,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.23
$45.62
P/E Ratio
$49.86
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$44.03
$12.89
52 Week High
$67.57
$31.74

Technical Indicators

Market Signals
Indicator
KBH
RCUS
Relative Strength Index (RSI) 35.35 40.17
Support Level $44.03 $22.92
Resistance Level $58.83 $26.43
Average True Range (ATR) 1.57 1.30
MACD 0.06 -0.05
Stochastic Oscillator 16.37 36.25

Price Performance

Historical Comparison
KBH
RCUS

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: